US-based healthcare performance improvement company Vizient has awarded a contract to Surfacide for UV-C solution that can help hospitals combat Covid-19.

Vizient serves more than half of the healthcare organizations across the country from large integrated delivery networks and academic medical centres to community hospitals, paediatric facilities and non-acute care providers.

Under the contract, Vizient members will get access to Surfacide’s multiple emitter UV-C solution that has become an integral part to protect patients as well as staff during uncertain times.

Surfacide founder and CEO Gunner Lyslo said: “Surfacide is proud of this contract with Vizient and proud to answer the urgent call from countless healthcare facilities that need a solution they can trust to deliver protection for healthcare workers and patients.

“Over the course of the last few months, we’ve seen UV-C technology emerge as a key tactic in combating coronavirus and other infections.”

The Surfacide solution is being deployed in facilities across the US as organisations implement solutions in the fight against the pandemic.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The UV-C solution system provides an automated UV-C decontamination technology that is capable of reducing bacteria, spores and viruses. It is also effective against various advanced viral infectious diseases.

Multiple automated UV-C emitters within the Helios work together and provide decontamination of the room in a short span of time offering an extra layer of protection.

Lyslo further added: “We are confident that Surfacide’s agreement with Vizient will allow more healthcare centres to have access to the Surfacide UV-C solution and slow the spread of Covid-19.”